Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 29, 1999 - Issue 4
14
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics of a new histamine H2-receptor antagonist, Z-300, in rat and dog

, , , , , , , & show all
Pages 425-433 | Published online: 22 Sep 2008

References

  • BAI, S. A. and ABRAMSON F. P., 1982, Interactions of phenobarbital with propranolol in the dog. 1. plasma protein binding. Journal of Pharmacology and Experimental Therapeutics, 222, 589–594.
  • DELLO, C. P., BELPAIRE, F. M., DERICKE RICK, A. and ERAEYMAN, N. H., 1988, Influence of inflammation on serum concentration, molecular heterogeneity and drug binding properties of canine alpha-1-acid glycoprotein. Journal of Veterinary Pharmacology and Therapy, 11, 71–76.
  • HELLERSTIN, M. K., SASAK, V., ORDOVAS, J. and MUNRO, H. N., 1985, Isolation of alpha-1-acid glycoprotein from human plasma using high-performance liquid chromatography. Analytical Biochemistry, 146, 366–371.
  • HOSHINO, M., WATANABE, Y., HAMASAKI, Y., MAsuaucHI, M. and OKAHIR A., 1993, Determination of a new 11-receptor antagonist Z-300 in plasma by high-performance liqid chromatography with fluorescence detection. Yakugaku Zasshi, 113, 586–590.
  • ICHIKAWA, T., ISHIHARA, K., OGATA, Y., OHARA, S., SAIGENJI, K. and HOTTA, K., 1994, Effects of Z-300, a new histamine FI-receptor antagonist, on mucin biosynthesis in rat gastric mucosa. Japanese Journal of Pharmacology, 65, 63–66.
  • JACKSON, P. R., TUCKER, G. T. and WOODS, H. F., 1982, Altered plasma drug binding in cancer: role of a -acid glycoprotein and albumin. Clinical and Pharmacological Therapeutics, 32, 295–302.
  • KAWAI, T., YAMAGISHI, Y. and KAWAI, T., 1977, Cellulose acetate electrophoresis using anew Separax-S membrane and its normal serum protein fractional values in adults and children. Japanese Journal of Electro, 20, 281–286.
  • KREMER, J. M. H., WILTING, J. and JANSSEN, L. H. M., 1988, Drug bindings to human alpha-1-acid glycoprotein in health and disease. Pharmacology Reviews, 40, 1–47.
  • MARUYAMA, T., OTAGIRI, M. and TAKADATE, A., 1990, Characterization of drug binding sites on acacid glycoprotein. Chemical and Pharmacological Bulletin, 38, 1688–1691.
  • OKABE, S., TAKAGI, K., IGATA, H., KATO, S., SHEVIOSAKO, K., YAMAJI, Y. and SEIKI, M., 1992, Effects of a new histamine FI-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine. Japanese Journal of Pharmacology, 59, 275-289. OTAGIRI, M., 1985, Structure and function of serum albumin. Metabolism, 22, 1207–1215.
  • SUGIHARA, N., FURUNO, K., KITA, N., MURAKAMI, T. and YATA, B., 1992, Plasma acacid glycoprotein concentration in rats with chemical liver injury. Chemical and Pharmacological Bulletin, 40, 2516–2519.
  • UMEMURA, K., UEMATSU, T., KOSUGE, K., NAKANO, M., MIZUNO, A., WADA, K. and NAKAJEVIA, M., 1994, Metabolic fate and the effect of the gastric pH of new FI-receptor antagonist Z-300. Japanese Journal of Clinical and Pharmacological Therapeutics, 25, 239–240.
  • YAMAOKA, K., TANIGAWARA, Y., NAKAGAwA, T. and UNO, T., 1981, A pharmacokinetic analysis program (MULTI) for microcomputer. Journal of Pharmacobio-Dynamics, 4, 879–885.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.